Brainsway (BWAY) Cash from Investing Activities (QoQ) (2018 - 2026)
Brainsway (BWAY) Cash from Investing Activities (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Brainsway | 598.04 Mn | 538.27 Mn | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -802.90% |
| Dec 31, 2025 | -175.68% |
| Sep 30, 2025 | 108.61% |
| Jun 30, 2025 | -706.66% |
| Mar 31, 2025 | -6.67% |
| Dec 31, 2024 | -38.16% |
| Sep 30, 2024 | -103.90% |
| Jun 30, 2024 | 4,916.62% |
| Mar 31, 2024 | 98.00% |
| Dec 31, 2023 | -6,907.11% |
| Sep 30, 2023 | 66.51% |
| Jun 30, 2023 | -2,460.94% |
| Mar 31, 2023 | -85.01% |
| Dec 31, 2022 | 359.14% |
| Sep 30, 2022 | -99.77% |
| Jun 30, 2022 | 4,437.86% |
| Mar 31, 2022 | 178.63% |
| Dec 31, 2021 | -682.19% |
| Sep 30, 2021 | 99.64% |
| Jun 30, 2021 | -10,598.94% |